Acurx Pharmaceuticals (ACXP) Interest Coverage Ratio: History & Chart

Acurx Pharmaceuticals, Inc.(ACXP)

Biotechnology · Staten Island, NY

$1.30-0.01 (-0.76%)

Delayed quote: Oct 6, 2026, 9:39 AM EDT

About Acurx Pharmaceuticals, Inc.

Acurx Pharmaceuticals, Inc. functions as a clinical-stage biopharmaceutical firm focused on developing innovative antibiotic treatments for bacterial infections. The company's primary drug candidate is ibezapolstat, an antibiotic that utilizes a novel mechanism of action by targeting the polymerase IIIC enzyme. Ibezapolstat has successfully completed Phase II clinical trials for addressing Clostridium difficile infections. Additionally, Acurx is progressing with ACX-375C, an investigational therapeutic suitable for both oral and injectable administration. This compound is being developed to combat various gram-positive bacteria, including resistant strains such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and penicillin-resistant Streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was established in 2017 and is headquartered in Staten Island, New York.

Staten Island, NY

4 employees

www.acurxpharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: David Luci

View full financials

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Acurx Pharmaceuticals, Inc. (ACXP)	$5.59M	N/A	N/A	N/A	N/A
Intelligent Bio Solutions Inc. (INBS)vs ›	$5.47M	-1174.37x	N/A	N/A	N/A
Alzamend Neuro Inc (ALZN)vs ›	$5.40M	1324.50x	1324.50x	1324.50x	1324.50x
Lucyd, Inc (LUCY)vs ›	$5.83M	N/A	N/A	N/A	N/A
Lunai Bioworks Inc. (LNAI)vs ›	$5.40M	-25.56x	N/A	N/A	N/A
Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs ›	$5.25M	-13.75x	N/A	N/A	N/A
Imunon, Inc. (IMNN)vs ›	$5.38M	N/A	1.00x	1.02x	1.02x
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs ›	$5.97M	-310.21x	N/A	N/A	N/A
Cardio Diagnostics Holdings, Inc. (CDIO)vs ›	$6.07M	-438.08x	N/A	N/A	N/A
Basel Medical Group Ltd Ordinary Shares (BMGL)vs ›	$5.01M	-10.70x	10.43x	9.52x	9.52x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Acurx Pharmaceuticals, Inc. (ACXP)

$5.59M

N/A

Intelligent Bio Solutions Inc. (INBS)vs ›

$5.47M

-1174.37x

N/A

Alzamend Neuro Inc (ALZN)vs ›